231 related articles for article (PubMed ID: 32415710)
41. Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis.
Abraham J; Sinnollareddy MG; Roberts MS; Williams P; Peake SL; Lipman J; Roberts JA
Int J Antimicrob Agents; 2019 Feb; 53(2):137-142. PubMed ID: 30296581
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial dosing in critical care: A pragmatic adult dosing nomogram.
Williams P; Beall G; Cotta MO; Roberts JA
Int J Antimicrob Agents; 2020 Feb; 55(2):105837. PubMed ID: 31722224
[TBL] [Abstract][Full Text] [Related]
43. A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors.
Hughes JH; Keizer RJ
CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1150-1160. PubMed ID: 34270885
[TBL] [Abstract][Full Text] [Related]
44. Predictability of serum vancomycin concentrations using the kinetic estimated glomerular filtration rate formula for critically ill patients
.
Harada D; Uchino S; Kawakubo T; Takinami M
Int J Clin Pharmacol Ther; 2018 Dec; 56(12):612-616. PubMed ID: 30220291
[TBL] [Abstract][Full Text] [Related]
45. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.
Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E
J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565
[TBL] [Abstract][Full Text] [Related]
47. AUC-based monitoring and model-informed precision dosing of vancomycin in critically ill patients: why and how?
Goutelle S; Wallet F; Thoma Y; Peclard JR; Bourguignon L; Cohen S; Kipnis E; Roberts J; Allaouchiche B; Friggeri A
Anaesth Crit Care Pain Med; 2023 Dec; 42(6):101286. PubMed ID: 37517689
[No Abstract] [Full Text] [Related]
48. Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
Genuini M; Oualha M; Bouazza N; Moulin F; Treluyer JM; Lesage F; Renolleau S; Benaboud S
Pediatr Crit Care Med; 2018 Jun; 19(6):e263-e269. PubMed ID: 29394210
[TBL] [Abstract][Full Text] [Related]
49. Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients.
Turner RB; Kojiro K; Shephard EA; Won R; Chang E; Chan D; Elbarbry F
Pharmacotherapy; 2018 Dec; 38(12):1174-1183. PubMed ID: 30362592
[TBL] [Abstract][Full Text] [Related]
50. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
Hill DM; Velamuri SR; Lanfranco J; Romero Legro I; Sinclair SE; Hickerson WL
Burns; 2019 Mar; 45(2):423-432. PubMed ID: 30340863
[TBL] [Abstract][Full Text] [Related]
51. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
52. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P
Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
[TBL] [Abstract][Full Text] [Related]
53. Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients.
Kallee S; Scharf C; Schatz LM; Paal M; Vogeser M; Irlbeck M; Zander J; Zoller M; Liebchen U
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145667
[TBL] [Abstract][Full Text] [Related]
54. A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients.
Kassel LE; Van Matre ET; Foster CJ; Fish DN; Mueller SW; Sherman DS; Wempe MF; MacLaren R; Neumann RT; Kiser TH
Pharmacotherapy; 2018 Sep; 38(9):921-934. PubMed ID: 29906310
[TBL] [Abstract][Full Text] [Related]
55. Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.
Elyasi S; Khalili H
Eur J Clin Pharmacol; 2016 Jul; 72(7):777-88. PubMed ID: 27117446
[TBL] [Abstract][Full Text] [Related]
56. Population pharmacokinetic parameters of vancomycin in critically ill patients.
Llopis-Salvia P; Jiménez-Torres NV
J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
[TBL] [Abstract][Full Text] [Related]
57. Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study.
Bakke V; Sporsem H; Von der Lippe E; Nordøy I; Lao Y; Nyrerød HC; Sandvik L; Hårvig KR; Bugge JF; Helset E
Acta Anaesthesiol Scand; 2017 Jul; 61(6):627-635. PubMed ID: 28444760
[TBL] [Abstract][Full Text] [Related]
58. A Free Open-Source Bayesian Vancomycin Dosing App for Adults: Design and Evaluation Study.
Oommen T; Thommandram A; Palanica A; Fossat Y
JMIR Form Res; 2022 Mar; 6(3):e30577. PubMed ID: 35353046
[TBL] [Abstract][Full Text] [Related]
59. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
Sirvent JM; Piñeiro L; de la Torre M; Motjé M; de Batlle J; Bonet A
Rev Esp Quimioter; 2010 Mar; 23(1):27-35. PubMed ID: 20232021
[TBL] [Abstract][Full Text] [Related]
60. Right Dose, Right Now: Development of AutoKinetics for Real Time Model Informed Precision Antibiotic Dosing Decision Support at the Bedside of Critically Ill Patients.
Roggeveen LF; Guo T; Driessen RH; Fleuren LM; Thoral P; van der Voort PHJ; Girbes ARJ; Bosman RJ; Elbers P
Front Pharmacol; 2020; 11():646. PubMed ID: 32499697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
